Evidence map›Paper›PMID 22195021›Full record

ArticlePloS one2011

Craniectomy for malignant cerebral infarction: prevalence and outcomes in US hospitals.

Brian P Walcott, Elena V Kuklina, Brian V Nahed, Mary G George, Kristopher T Kahle, J Marc Simard, Wael F Asaad, Jean-Valery C E Coumans

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Role of early decompressive craniectomy in traumatic brain injury: Our clinical experience.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Association of APOE Gene Polymorphisms with Cerebral Infarction in the Chinese Population.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.International journal of molecular sciences · 2015
    Review
  19. Article
  20. Malignant cerebral edema after large anterior circulation infarction: a review.Current treatment options in cardiovascular medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Brian P WalcottDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America. walcott.brian@mgh.harvard.edu
Elena V Kuklina
Brian V Nahed
Mary G George
Kristopher T Kahle
J Marc Simard
Wael F Asaad
Jean-Valery C E Coumans
Centers for Disease Control and Prevention · USHarvard University · USMassachusetts General Hospital · USBrown University · USUniversity of Maryland, Baltimore · US

Funding

Sulfonylurea receptor 1 (SUR1)- A novel therapeutic target in ischemic strokeR01HL082517 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SIMARD, J. MARC · 2006 to 2021
$5.6M
NHLBI NIH HHS R01 HL082517
6 · The paper itself

Abstract

objectRandomized trials have demonstrated the efficacy of craniectomy for the treatment of malignant cerebral edema following ischemic stroke. We sought to determine the prevalence and outcomes related to this by using a national database.

methodsPatient discharges with ischemic stroke as the primary diagnosis undergoing craniectomy were queried from the US Nationwide Inpatient Sample from 1999 to 2008. A subpopulation of patients was identified that underwent thrombolysis. Two primary end points were examined: in-hospital mortality and discharge to home/routine care. To facilitate interpretations, adjusted prevalence was calculated from the overall prevalence and two age-specific logistic regression models. The predictive margin was then generated using a multivariate logistic regression model to estimate the probability of in-hospital mortality after adjustment for admission type, admission source, length of stay, total hospital charges, chronic comorbidities, and medical complications.

resultsAfter excluding 71,996 patients with the diagnosis of intracranial hemorrhage and posterior intracranial circulation occlusion, we identified 4,248,955 adult hospitalizations with ischemic stroke as a primary diagnosis. The estimated rates of hospitalizations in craniectomy per 10,000 hospitalizations with ischemic stroke increased from 3.9 in 1999-2000 to 14.46 in 2007-2008 (p for linear trend<0.001). Patients 60+ years of age had in-hospital mortality of 44% while the 18-59 year old group was found to be 24% (p = 0.14). Outcomes were comparable if recombinant tissue plasminogen activator had been administered.

conclusionsCraniectomy is being increasingly performed for malignant cerebral edema following large territory cerebral ischemia. We suspect that the increase in the annual incidence of DC for malignant cerebral edema is directly related to the expanding collection of evidence in randomized trials that the operation is efficacious when performed in the correct patient population. In hospital mortality is high for all patients undergoing this procedure.

Indexed as

AdolescentAdultCerebral InfarctionDecompressive CraniectomyHospitalizationHospital MortalityHospitalsHumansMiddle AgedPrevalenceStrokeTissue Plasminogen ActivatorTreatment OutcomeUnited StatesYoung AdultTissue Plasminogen Activator

Identifiers

PMID22195021
PMCPMC3237608
OpenAlexW2076953438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.